Hematopoietic cell transplantation activity increased from 2005 to 2013 by 25% in Australia and 52% in New Zealand.
Allografts for recipients ages 60 + increased from 7.5% to 15.4% from 2005 to 2013.
Autografts for recipients ages 60 + increased from 32.3% to 45.4% from 2005 to 2013.
Major indications for transplantation were acute myeloid leukemia, acute lymphoblastic leukemia, multiple myeloma, and non-Hodgkin lymphoma.
A number of indications showed an improvement in overall survival over time.